Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis

Neurogenetics

Volumn 3, Issue 4, 2001, Pages 221-230

  Boon, Maartje ^a   Nolte, Ilja M ^b   Bruinenberg, Marcel ^b   Spijker, Geert T ^b   Terpstra, Peter ^b   Raelson, John ^c   De Keyser, Jacques ^a   Zwanikken, Cees P ^a   Hulsbeek, Miriam ^b   Hofstra, Robert M W ^b   Buys, Charles H C M ^b   Te Meerman, Gerard J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Galileo Genomics   (Canada)

Author keywords

Genes; Haplotype sharing; Human leukocyte antigens; Linkage disequilibrium; Multiple sclerosis

Indexed keywords

PRIMER DNA;

ARTICLE; CLUSTER ANALYSIS; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HISTOCOMPATIBILITY TEST; HUMAN; MULTIPLE SCLEROSIS;

CLUSTER ANALYSIS; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HUMAN; LINKAGE DISEQUILIBRIUM; MULTIPLE SCLEROSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0035491287     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100480100121     Document Type: Article

References (68)

1. Karpuj MV, Steinman L, Oksenberg JR (1997) Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects. Neurogenetics 1:21-28
2. Sadovnick AD, Baird PA, Ward RH (1988) Multiple sclerosis: updated risks for relatives. Am J Med Genet 29:533-541
3. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA (1996) Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 119:449-455
4. Carton H, Vlietinck R, Debruyne J, De Keyser J, D'Hooghe MB, Loos R, Medaer R, Truyen L, Yee IM, Sadovnick AD (1997) Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 62:329-333
5. Olerup O, Hillert J (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38:1-15
6. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Möller E, Carlsson B, Wallin J (1989) Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A 86:7113-7117
7. Hillert J, Olerup O (1993) Multiple sclerosis is associated with genes within or close to the HLA- DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype. Neurology 43:163-168
8. Hillert J, Gronning M, Nyland H, Link H, Olerup O (1992) An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psychiatry 55:887-890
9. Marrosu MG, Murru MR, Costa G, Cucca F, Sotgiu S, Rosati G, Muntoni F (1997) Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 61:454-457
10. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F (1998) DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7:1235-1237
11. Kellar-Wood HF, Wood NW, Holmans P, Clayton D, Robertson N, Compston DA (1995) Multiple sclerosis and the HLA-D region: linkage and association studies. J Neuroimmunol 58:183-190
12. Fogdell A, Olerup O, Fredrikson S, Vrethem M, Hillert J (1997) Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis. Neurology 48:758-762
13. Jersild C, Svejgaard A, Fog T (1972) HL-A antigens and multiple sclerosis. Lancet 1:1240-1241
14. Naito S, Namerow N, Mickey MR, Terasaki PI (1972) Multiple sclerosis: association with HL-A3. Tissue Antigens 2:1-4
15. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464-468
16. Haines JL, Ter Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, Gartioux C, Reyes C, Ribierre F, Gyapay G, Weissenbach J, Hauser SL, Goodkin DE, Lincoln R, Usuku K, Oksenberg JR (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469-471
17. Epplen C, Jackel S, Santas EJ, D'Souza M, Poehlau D, Dotzauer B, Sindern E, Haupts M, Rude KP, Weber F, Stover J, Poser S, Gehler W, Malin JP, Przuntek H, Epplen JT (1997) Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 41:341-352
18. Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C, Goodfellow PN, Compston A (1998) HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 2:24-33
19. Degli-Esposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL (1992) Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol 34: 242-252
20. Cullen M, Noble J, Erlich H, Thorpe K, Beck S, Klitz W, Trowsdale J, Carrington M (1997) Characterization of recombination in the HLA class II region. Am J Hum Genet 60:397-407
21. Carrington M (1999) Recombination within the human MHC. Immunol Rev 167:245-256
22. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
23. Ajioka RS, Jorde LB, Gruen JR, Yu P, Dimitrova D, Barrow J, Radisky E, Edwards CQ, Griffen LM, Kushner JP (1997) Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 60:1439-1447
24. Thomas W, Fullan A, Loeb DB, McClelland EE, Bacon BR, Wolff RK (1998) A haplotype and linkage disequilibrium analysis of the hereditary hemochromatosis gene region. Hum Genet 102:517-525
25. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66:1833-1844
26. Beckmann L, Fischer C, Deck K-G, Nolte IM, te Meerman GJ, Chang-Claude J (2001) Exploring haplotype sharing methods in general and isolated populations to detect gene(s) of a complex trait. Genet Epidemiol (in press)
27. Levinson DF, Nolte IM, te Meerman GJ (2001) Haplotype sharing tests of linkage disequilibrium in a hutterite asthma dataset. Genet Epidemiol (in press)
28. Levinson DF, Kirby A, Slepner S, Nolte IM, Spijker GT, te Meerman GJ (2001) Simulation studies of detection of a complex disease in a partially isolated population. Am J Med Genet 105:65-70
29. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
30. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
31. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Kazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154
32. Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tome P, Hui L, Matise TC, McKusick KB, Beckmann JS, Bentolila S, Bihoreau M, Birren BB, Browne J, Butler A, Castle AB, Chiannilkulchai N, Clee C, Day PJ, Dehejia A, Dibling T, Drouot N, Duprat S, Fizames C, Bentley DR (1998) A physical map of 30,000 human genes. Science 282:744-746
33. The MHC Sequencing Consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401:921-923
34. te Meerman GJ, van der Meulen MA, Sandkuijl LA (1995) Perspectives of identity by descent (IBD) mapping in founder populations. Clin Exp Allergy 25 [Suppl 2]:97-102
35. te Meerman GJ, van der Meulen MA (1997) Genomic sharing surrounding alleles identical by descent: effects of genetic drift and population growth. Genet Epidemiol 14:1125-1130
36. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516
37. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B (1973) Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 2: 1221-1225
38. Opelz G, Terasaki P, Myers L, Ellison G, Ebers G, Zabriskie J, Weiner H, Kempe H, Sibley W (1977) The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States. Tissue Antigens 9:54-58
39. Francis DA, Batchelor JR, McDonald WI, Hing SN, Dodi IA, Fielder AH, Hern JE, Downie AW (1987) Multiple sclerosis in north-east Scotland. An association with HLA-DQw1. Brain 110:181-196
40. Marrosu MG, Muntoni F, Murru MR, Spinicci G, Pischedda MP, Goddi F, Cossu P, Pirastu M (1988) Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology 38:1749-1753
41. Spurkland A, Rønningen KS, Vandvik B, Thorsby E, Vartdal F (1991) HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 30:69-75
42. Kwon OJ, Kami A, Israel S, Brautbar C, Amar A, Meiner Z, Abramsky O, Karussis D (1999) HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol 56:555-560
43. Service SK, Lang DW, Freimer NB, Sandkuijl LA (1999) Linkage-disequilibrium mapping of disease genes by reconstruction of ancestral haplotypes in founder populations. Am J Hum Genet 64:1728-1738
44. McPeek MS, Strahs A (1999) Assessment of linkage disequilibrium by the decay of haplotype sharing, with application to fine-scale genetic mapping. Am J Hum Genet 65:858-875
45. Clayton D, Jones H (1999) Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet 65: 1161-1169
46. Morris AP, Whittaker JC, Balding DJ (2000) Bayesian fine-scale mapping of disease loci, by hidden Markov models. Am J Hum Genet 67:155-169
47. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O'Connor P, Nath A, Auty A, Metz L, Francis G, Paulseth JE, Murray TJ, Pryse-Phillips W, Risch N (1996) A full genome search in multiple sclerosis. Nat Genet 13:472-476
48. Ebers GC, Sadovnick AD (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54:1-17
49. Oksenberg JR, Hauser SL (1997) New insights into the immunogenetics of multiple sclerosis. Curr Opin Neurol 10: 181-185
50. Hogancamp WE, Rodriguez M, Weinshenker BG (1997) Identification of multiple sclerosis-associated genes. Mayo Clin Proc 72:965-976
51. Fogdell-Hahn A, Ligers A, Grønning M, Hillert J, Olerup O (2000) Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55:140-148
52. Marcadet A, Massart C, Semana G, Fauchet R, Sabouraud O, Merienne M, Dausset J, Cohen D (1985) Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis. Immunogenetics 22:93-96
53. Vartdal F, Sollid LM, Vandvik B, Markussen G, Thorsby E (1989) Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. Hum Immunol 25:103-110
54. Haegert DG, Francis GS (1992) Contribution of a single DQ beta chain residue to multiple sclerosis in French Canadians. Hum Immunol 34:85-90
55. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U (1994) Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 39:41-48
56. Francis DA, Thompson AJ, Brookes P, Davey N, Lechler RI, McDonald WI, Batchelor JR (1991) Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ? Hum Immunol 32:119-124
57. Haegert DG, Muntoni F, Murru MR, Costa G, Francis GS, Marrosu MG (1993) HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups. Neurology 43:548-552
58. Haegert DG, Francis GS (1993) HLA-DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two Canadian patient groups. Neurology 43:1207-1210
59. Haegert DG, Swift FV, Benedikz J (1996) Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 46:1107-1111
60. Kálmán B, Takács K, Gyódi E, Kramer J, Füst G, Tauszik T, Guseo A, Kuntár L, Komoly S, Nagy C (1991) Sclerosis multiplex in gypsies. Acta Neurol Scand 84:181-185
61. Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL (1992) Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 19:11-19
62. Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F (1997) The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer. Tissue Antigens 50:15-22
63. Caballero A, Alvés-León S, Papais-Alvarenga R, Fernández O, Navarro G, Alonso A (1999) DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Tissue Antigens 54:524-526
64. Ono T, Zambenedetti MR, Yamasaki K, Kawano Y, Kamikawaji N, Ito H, Sakurai M, Nishimura Y, Kira J, Kanazawa I, Sasazuki T (1998) Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA- DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). Tissue Antigens 52:539-542
65. Tiwari JL, Terasaki PI (1985) Multiple sclerosis. HLA and disease associations. Springer, New York, pp 152-167
66. Dørum A, Moller P, Kamsteeg EJ, Scheffer H, Burton M, Heimdal KR, Mæhle LO, Hovig E, Tropé CG, van der Hout AH, van der Meulen MA, Buys CH, te Meerman GJ (1997) A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. Eur J Cancer 33:2390-2392
67. RischN, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516-1517
68. Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, Walters L (1998) New goals for the U.S. Human Genome Project: 1998-2003. Science 282:682-689